Skip to main content
Log in

Association Between Osteopontin Gene Polymorphisms and Cerebral Palsy in a Chinese Population

  • Original Paper
  • Published:
NeuroMolecular Medicine Aims and scope Submit manuscript

Abstract

Cerebral palsy (CP) is a neurological disorder affecting movement and posture that develops as a complication of prenatal, perinatal, and postnatal brain injury. Such non-progressive brain injury is often accompanied by neonatal encephalopathy and inflammation. The widely expressed soluble cytokine osteopontin (OPN) plays an important role in inflammation and neurological protection. Therefore, it is of great interest to study the relationship between CP and genetic variants of OPN. To explore the genetic association between OPN gene single nucleotide polymorphisms (SNPs) and CP in the Chinese Han population, five SNPs (rs2853744, rs2853749, rs11728697, rs4754, and rs1126616) were genotyped among 715 CP patients and 658 healthy controls using the MassArray platform. Statistical analysis was performed using the online SHEsis program, and Bonferroni correction was applied as necessary. We found an association between rs1126616 and global CP (corrected allelic P = 0.0006 and genotypic P = 0.0011 after Bonferroni correction). The other SNPs were not statistically associated with CP or any of its subgroups. By testing a relatively large sample size, our study demonstrates that the OPN gene SNP rs1126616 is statistically associated with CP. We suspect that the OPN gene might be a susceptibility factor for CP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Albertsson, A. M., Zhang, X., Leavenworth, J., Bi, D., Nair, S., Qiao, L., et al. (2014). The effect of osteopontin and osteopontin-derived peptides on preterm brain injury. Journal of Neuroinflammation, 11(1), 197.

    Article  PubMed  PubMed Central  Google Scholar 

  • Arjomandi, M., Galanter, J. M., Choudhry, S., Eng, C., Hu, D., Beckman, K., et al. (2011). Polymorphism in osteopontin gene (SPP1) is associated with asthma and related phenotypes in a Puerto Rican population. Pediatric allergy, immunology, and pulmonology, 24(4), 207–214.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., et al. (2000). Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science, 287(5454), 860–864.

    Article  CAS  PubMed  Google Scholar 

  • Bi, D., Chen, M., Zhang, X., Wang, H., Xia, L., Shang, Q., et al. (2014). The association between sex-related interleukin-6 gene polymorphisms and the risk for cerebral palsy. Journal of Neuroinflammation, 11, 100.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bonestroo, H. J., Nijboer, C. H., van Velthoven, C. T., van Bel, F., & Heijnen, C. J. (2015). The neonatal brain is not protected by osteopontin peptide treatment after hypoxia-ischemia. Developmental Neuroscience, 37(2), 142–152.

    Article  CAS  PubMed  Google Scholar 

  • Brown, A. (2012). Osteopontin: A key link between immunity, inflammation and the central nervous system. Translational Neuroscience, 3(3), 288–293.

    Article  PubMed  PubMed Central  Google Scholar 

  • Chen, M., Li, T., Lin, S., Bi, D., Zhu, D., Shang, Q., et al. (2013). Association of Interleukin 6 gene polymorphisms with genetic susceptibilities to spastic tetraplegia in males: a case-control study. Cytokine, 61(3), 826–830.

    Article  CAS  PubMed  Google Scholar 

  • Costeff, H. (2004). Estimated frequency of genetic and nongenetic causes of congenital idiopathic cerebral palsy in west Sweden. Annals of Human Genetics, 68(Pt 5), 515–520.

    Article  CAS  PubMed  Google Scholar 

  • Dammann, O. (2007). Persistent neuro-inflammation in cerebral palsy: A therapeutic window of opportunity? Acta Paediatrica, 96(1), 6–7.

    Article  PubMed  Google Scholar 

  • Fan, Y., Zhang, X., Yang, Z. H., Sun, X. W., Li, S. N., Zhong, L., et al. (2013). The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma. DNA and Cell Biology, 32(10), 594–600.

    Article  CAS  PubMed  Google Scholar 

  • Fleiss, B., & Gressens, P. (2012). Tertiary mechanisms of brain damage: A new hope for treatment of cerebral palsy? Lancet Neurology, 11(6), 556–566.

    Article  PubMed  Google Scholar 

  • Forton, A. C., Petri, M. A., Goldman, D., & Sullivan, K. E. (2002). An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Human Mutation, 19(4), 459.

    Article  CAS  PubMed  Google Scholar 

  • Gibson, C. S., Maclennan, A. H., Dekker, G. A., Goldwater, P. N., Sullivan, T. R., Munroe, D. J., et al. (2008). Candidate genes and cerebral palsy: A population-based study. Pediatrics, 122(5), 1079–1085.

    Article  PubMed  Google Scholar 

  • Girard, S., Kadhim, H., Roy, M., Lavoie, K., Brochu, M. E., Larouche, A., & Sebire, G. (2009). Role of perinatal inflammation in cerebral palsy. Pediatric Neurology, 40(3), 168–174.

    Article  PubMed  Google Scholar 

  • Glas, J., Seiderer, J., Bayrle, C., Wetzke, M., Fries, C., Tillack, C., et al. (2011). The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn’s disease. PLoS ONE, 6(12), e29309.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hashimoto, M., Sun, D., Rittling, S. R., Denhardt, D. T., & Young, W. (2007). Osteopontin-deficient mice exhibit less inflammation, greater tissue damage, and impaired locomotor recovery from spinal cord injury compared with wild-type controls. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience, 27(13), 3603–3611.

    Article  CAS  Google Scholar 

  • Jan, M. M. (2006). Cerebral palsy: Comprehensive review and update. Annals of Saudi medicine, 26(2), 123–132.

    PubMed  Google Scholar 

  • Li, Z., Zhang, Z., He, Z., Tang, W., Li, T., Zeng, Z., et al. (2009). A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Research, 19(4), 519–523.

    Article  CAS  PubMed  Google Scholar 

  • MacLennan, A. H., Thompson, S. C., & Gecz, J. (2015). Cerebral palsy: Causes, pathways, and the role of genetic variants. American Journal of Obstetrics and Gynecology, 213(6), 779–788.

    Article  PubMed  Google Scholar 

  • Nelson, K. B., & Blair, E. (2015). Prenatal factors in singletons with cerebral palsy born at or near term. The New England Journal of Medicine, 373(10), 946–953.

    Article  CAS  PubMed  Google Scholar 

  • Nelson, K. B., & Grether, J. K. (1999). Causes of cerebral palsy. Current Opinion in Pediatrics, 11(6), 487–491.

    Article  CAS  PubMed  Google Scholar 

  • Nelson, K. B., & Willoughby, R. E. (2000). Infection, inflammation and the risk of cerebral palsy. Current Opinion in Neurology, 13(2), 133–139.

    Article  CAS  PubMed  Google Scholar 

  • Rosenbaum, P., Paneth, N., Leviton, A., Goldstein, M., Bax, M., Damiano, D., et al. (2007). A report: The definition and classification of cerebral palsy April 2006. Developmental Medicine and Child Neurology. Supplement, 109, 8–14.

    PubMed  Google Scholar 

  • Safarinejad, M. R., Shafiei, N., & Safarinejad, S. (2013). Association between polymorphisms in osteopontin gene (SPP1) and first episode calcium oxalate urolithiasis. Urolithiasis, 41(4), 303–313.

    Article  CAS  PubMed  Google Scholar 

  • Shi, Y. Y., & He, L. (2005). SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Research, 15(2), 97–98.

    Article  CAS  PubMed  Google Scholar 

  • Surveillance of Cerebral Palsy in Europe (SCPE). (2000). Surveillance of cerebral palsy in Europe: A collaboration of cerebral palsy surveys and registers. Developmental Medicine and Child Neurology, 42(12), 816–824.

    Article  Google Scholar 

  • The Child Rehabilitation Committee of Chinese Rehabilitation Medical Association. (2007). The definition of cerebral palsy, classification and diagnosis. Chinese Journal of Physical Medicine and Rehabilitation, 29(5), 309.

    Google Scholar 

  • Tollanes, M. C., Wilcox, A. J., Lie, R. T., & Moster, D. (2014). Familial risk of cerebral palsy: population based cohort study. BMJ, 349, g4294.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tugcu, V., Simsek, A., Tarhan, T., Atalar, F., Bitkin, A., Tasci, A. I., et al. (2013). OPN gene polymorphism (Ala250) and lower serum OPN levels are associated with urolithiasis. Renal Failure, 35(6), 825–829.

    Article  CAS  PubMed  Google Scholar 

  • van Velthoven, C. T., Heijnen, C. J., van Bel, F., & Kavelaars, A. (2011). Osteopontin enhances endogenous repair after neonatal hypoxic-ischemic brain injury. Stroke, 42(8), 2294–2301.

    Article  PubMed  Google Scholar 

  • Wang, P. H., Liu, Y. F., Tsai, H. T., Tee, Y. T., Lin, L. Y., Hsieh, Y. H., & Yang, S. F. (2010). Elevated plasma osteopontin level is associated with pelvic inflammatory disease. Reproductive sciences, 17(11), 1052–1058.

    Article  CAS  PubMed  Google Scholar 

  • Wang, H., Xu, Y., Chen, M., Shang, Q., Sun, Y., Zhu, D., et al. (2013). Genetic association study of adaptor protein complex 4 with cerebral palsy in a Han Chinese population. Molecular Biology Reports, 40(11), 6459–6467.

    Article  CAS  PubMed  Google Scholar 

  • Wu, Y. W., Croen, L. A., Torres, A. R., Van De Water, J., Grether, J. K., & Hsu, N. N. (2009). Interleukin-6 genotype and risk for cerebral palsy in term and near-term infants. Annals of neurology, 66(5), 663–670.

    Article  CAS  PubMed  Google Scholar 

  • Wu, Y. W., Escobar, G. J., Grether, J. K., Croen, L. A., Greene, J. D., & Newman, T. B. (2003). Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA, 290(20), 2677–2684.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are grateful to all participants in this study. This work was supported by grants from the Shanghai Municipal Commission of Science and Technology Program (14DJ1400100), the National Natural Science Foundation of China (Nos: 90919049, 31271152, 81261120400, 31371274, 81300556), the 973 Program (2011CB504501), the Health Department of Henan Province (201201002), the Department of Science and Technology of Henan Province (134200510023), the Swedish Research Council (VR), and Swedish governmental grants to scientists working in health care (ALF).

Authors’ Contributions

SQ and CZ collected samples and prepared the manuscript. SQ, CZ, DL, WL, and Xiaoli Zhang recruited patients and collected clinical information. MC and DB performed experiments and data analysis. YX, FW, and Xiaoli Zhang analyzed data. Xinzhi Zhao, LW critically reviewed the manuscript. CZ and QX conceived and supervised the project. All authors read and approved the final manuscript.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Changlian Zhu or Qinghe Xing.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Additional information

Qing Shang and Chongchen Zhou have contributed equally.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shang, Q., Zhou, C., Liu, D. et al. Association Between Osteopontin Gene Polymorphisms and Cerebral Palsy in a Chinese Population. Neuromol Med 18, 232–238 (2016). https://doi.org/10.1007/s12017-016-8397-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12017-016-8397-7

Keywords

Navigation